FDA Announces Baxter’s Voluntary Nationwide Recall of One Lot of Heparin Sodium 0.9% Sodium Chloride Injection
On August 6, 2024, the U.S. Food and Drug Administration (FDA) reported that Baxter International Inc. is voluntarily recalling one lot of heparin sodium in 0.9% sodium chloride injection to the consumer level because of the potential for elevated endotoxin levels.